Physician profile
Eric A Heller
NPI 1073764718
$23,833.79
in general payments reported to CMS, 2019-2025
47 companies · $2,027 in 2025
The $2,027 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,200 · 2020: $532 · 2021: $539 · 2022: $1,926 · 2023: $2,146 · 2024: $11K · 2025: $2,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $7,019 · Food and Beverage: $5,085 · Grant: $3,333 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $7,019.38 |
| Food and Beverage | $5,084.84 |
| Grant | $3,333.33 |
| Education | $198.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,716.92 | 2022-2025 | Corevalve Evolut R |
| Abbott Laboratories | $4,802.98 | 2019-2025 | Mitraclip, Aveir, Amplatzer Amulet |
| Novartis Pharmaceuticals Corporation | $971.42 | 2019-2025 | |
| Boston Scientific Corporation | $704.84 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Watchman Access System |
| Edwards Lifesciences Corporation | $602.91 | 2023-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Amgen INC. | $544.59 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $481.49 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $443.25 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $350.41 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $323.47 | 2022-2025 | Camzyos, Eliquis |
| Pfizer INC. | $317.29 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $307.43 | 2019-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $293.39 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $261.85 | 2021-2025 | Verquvo |
| Heartflow, INC. | $259.75 | 2019-2023 | Ffrct |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $237.71 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Medtronic Vascular, INC. | $227.64 | 2019-2020 | |
| Acist Medical Systems, INC. | $208.10 | 2024 | |
| Novo Nordisk INC | $168.20 | 2023-2025 | Wegovy, Ozempic |
| Cvrx, INC. | $141.89 | 2023-2025 | Barostim Neo System |
| Abiomed | $138.18 | 2023-2025 | Impella |
| Biocompatibles, INC. | $132.25 | 2019 | |
| Kestra Medical Technology Services, INC. | $121.33 | 2023-2025 | Assure Wcd |
| Kiniksa Pharmaceuticals, Ltd. | $117.23 | 2022-2023 | Arcalyst |
| Atricure, INC. | $111.37 | 2022-2023 | |
| Acutus Medical, INC. | $99.82 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.93 | 2021-2023 | Lifevest |
| Impulse Dynamics (USA) INC. | $94.89 | 2022-2024 | Optimizer |
| Shockwave Medical, INC | $56.65 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $53.35 | 2022 | |
| Chiesi USA, INC. | $49.86 | 2019-2022 | |
| Lilly USA, LLC | $49.14 | 2025 | Zepbound, Mounjaro |
| Lexicon Pharmaceuticals, INC. | $44.01 | 2024 | |
| Amarin Pharma, INC. | $39.65 | 2019-2022 | |
| Glaxosmithkline, LLC. | $32.50 | 2025 | Shingrix, Arexvy |
| Kiniksa Pharmaceuticals International, Plc | $32.33 | 2024 | Arcalyst |
| Cook Medical LLC | $27.76 | 2022 | |
| Teleflex LLC | $25.81 | 2021 | |
| Cardiovascular Systems INC. | $25.75 | 2019 | |
| Esperion Therapeutics, INC. | $24.79 | 2025 | Nexletol |
| Biotronik INC. | $17.11 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $16.16 | 2024 | Rhythm Express |
| Ge Healthcare | $15.44 | 2021 | |
| Penumbra, INC. | $15.05 | 2024 | Indigo System |
| Asahi Intecc USA, INC. | $13.60 | 2020 | |
| Terumo Medical Corporation | $11.80 | 2019 | |
| Bardy Diagnostics, INC. | $7.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.